Date: 14-19 September 2025
Venue: Särö (Gothenburg), Sweden
Webinar 1: Key Points of the Hypertension Guidelines – The ESH MASTERplan for hypertension
Webinar 2: Managing Hypertensive Patients in Clinical Practice – Update on the management of hypertension and cardiac disease
Milan – May 23-26
MICO Congresso Center
FEBRUARY 21, 2025 – OPENING SUBMISSION LATE-BREAKERS ABSTRACTS
PART 1: Updates on resistant hypertension from novel lifestyle interventions to new drugs and interventional therapies
PART 2: Hypertension treatment challenges and options in comorbidities
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Endorsed by the European Federation of Internal Medicine (EFIM), European Renal Association (ERA), and International Society of Hypertension (ISH)
The ESH 2024 Clinical Practice Guidelines provide a novel concise format that supports the dissemination of the most important information of the Guidelines for the management and its implementation into clinical practice.
2023 ESH Hypertension Guidelines
The European Society of Hypertension (ESH) released the updated and expanded 2023 ESH Guidelines for the Management of Arterial Hypertension at the 32nd Annual European Meeting on Hypertension and Cardiovascular Protection Meeting in Milan, Italy.
The full final version of the guidelines is available on the Journal of Hypertension website.
Join Us for the ESH General Assembly at the 2025 Annual Meeting
The European Society of Hypertension invites all ESH members to attend the ESH General Assembly, taking place during the ESH 2025 Annual Meeting in Milan, Italy.
🔹 Date: Sunday, May 25, 2025
🔹 Time: 11:15 AM – 12:00 PM CEST
🔹 Venue: Allianz MiCo | Room: Aria 1
🔹 View the Agenda
ESH CKD Real-World-Evidence Research:
“Deficits in CKD screening and management in European patients with hypertension–A call to action”
In 2024, the ESH conducted a survey among its Excellence Centres on CKD management in hypertensive patients. Our research has identified several gaps in CKD management, prompting us to issue a Call to Action to address these critical issues.